Initial experiences of maintaining atrioventricular intrinsic conduction during cardiac resynchronization therapy in non-responders

Chinese Medical Journal

Volumn 122, Issue 20, 2009, Pages 2455-2460

  Wang, Ru Xing ^a,b   Guo, Tao ^a   Hua, Bao Tong ^a   Han, Ming Hua ^a   Zhao, Ling ^a   Yang, Jun ^a   Li, Shu Min ^a   Liu, Zhong Mei ^a   Luo, Zhi Ling ^a  

^a KUNMING MEDICAL UNIVERSITY   (China)

^b NANJING MEDICAL UNIVERSITY   (China)

Author keywords

Atrioventricular intrinsic conduction; Cardiac resynchronization therapy; Heart failure; Non responder

Indexed keywords

DIGOXIN; DIURETIC AGENT;

ADULT; AGED; ARTICLE; ATRIOVENTRICULAR CONDUCTION; CARDIAC RESYNCHRONIZATION THERAPY; CLINICAL ARTICLE; CONGESTIVE CARDIOMYOPATHY; CONTROLLED STUDY; DRUG DOSE REDUCTION; EXERCISE TOLERANCE; FEMALE; HEART FAILURE; HEART HEMODYNAMICS; HUMAN; IMPLANTATION; MALE; POSTOPERATIVE PERIOD; QRS COMPLEX; QUALITY OF LIFE; THERAPY EFFECT; TREATMENT RESPONSE;

ATRIOVENTRICULAR BLOCK; CARDIAC PACING, ARTIFICIAL; ECHOCARDIOGRAPHY; FEMALE; HEART FAILURE; HUMANS; MALE; MIDDLE AGED; TREATMENT OUTCOME;

EID: 70350728974     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0366-6999.2009.20.011     Document Type: Article

References (24)

1. Hasan A, Abraham WT. Cardiac resynchronization treatment of heart failure. Annu Rev Med 2006; 58: 63-74.
2. Bristow MR, Saxon LA, Boehmer J, Krueger S, Kass DA, De Marco T, et al. Comparison of Medical Therapy, Pacing, and Defibrillation in Heart Failure (COMPANION) Investigators. Cardiac resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med 2004; 350: 2140-2150.
3. Cleland JG, Daubert JC, Erdmann E, Gras D, Kappenberger L, Tavazzi L. Cardiac Resynchronization-Heart Failure (CARE-HF) Study Investigators. The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med 2005; 352: 1539-1549. (Pubitemid 40517094)
4. Swedberg K, Cleland J, Dargie H, Drexler H, Follath F, Komajda M, et al. Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005): The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology. Eur Heart J 2005; 26: 1115-1140.
5. Yoshida K, Yokoyama Y, Seo Y, Sekiguchi Y, Aonuma K. Triangle ventricular pacing in a non-responder to conventional biventricular pacing. Europace 2008; 10:502-504. (Pubitemid 351767668)
6. Sweeney MO, Hellkamp AS, Ellenbogen KA, Greenspon AJ, Freedman RA, Lee KL, et al. Adverse effect of ventricular pacing on heart failure and atrial fibrillation among patients with normal baseline QRS duration in a clinical trial of pacemaker therapy for sinus node dysfunction. Circulation 2003; 6: 2932-2937.
7. Leclercq C, Gadler F, Kranig W, Ellery S, Gras D, Lazarus A, et al. A randomized comparison of triple-site versus dual-site ventricular stimulation in patients with congestive heart failure. J Am Coll Cardiol 2008; 51: 1455-1462.
8. Yu CM, Wing-Hong Fung J, Zhang Q, Sanderson JE. Understanding non-responders of cardiac resynchronization therapy - current and future perspectives. J Cardiovasc Electrophysiol 2005; 16: 1117-1124. (Pubitemid 43920036)
9. Niu HX, Hua W, Zhang S, Sun X, Chen KP, Wang FZ, et al. Optimized cardiac resynchronization therapy in patients with congestive heart failure. Chin Med J 2007; 120: 605-607. (Pubitemid 46629919)
10. Blanc JJ, Etienne Y, Gilard M, Mansourati J, Munier S, Boschat J, et al. Evaluation of different ventricular pacing sites in patients with severe heart failure. Results of an acute hemodynamic study. Circulation 1997; 96: 3273-3277.
11. Vanderheyden M, Mullens W, Delrue L, Goethals M, de Bruyne B, Wijns W, et al. Myocardial gene expression in heart failure patients treated with cardiac resynchronization therapy responders versus non-responders. J Am Coll Cardiol 2008; 51: 129-136.
12. Deshmukh P, Casavant DA, Romanyshyn M, Anderson K. Permanent, direct His-bundle pacing: a novel approach to cardiac pacing in patients with normal His-Purkinje activation. Circulation 2000; 101: 869-877. (Pubitemid 30117882)
13. Sweeney MO, Ellenbogen KA, Casavant D, Betzold R, Sheldon T, Tang F, et al. Multicenter, prospective, randomized safety and efficacy study of a new atrial-based managed ventricular pacing mode (MVP) in dual chamber ICDs. J Cardiovasc Electrophysiol 2005; 8: 811-817.
14. van Gelder BM, Bracke FA, Meijer A, Pijls NH. The hemodynamic effect of intrinsic conduction during left ventricular pacing as compared to biventricular pacing. J Am Coll Cardiol 2005; 46: 2305-2310.
15. Birnie DH, Tang AS. The problem of non-response to cardiac resynchronization therapy. Curr Opin Cardiol 2006; 21: 20-26. (Pubitemid 43194328)
16. Stevenson WG, Sweeney MO. Single site left ventricular pacing for cardiac resynchronization. Circulation 2004; 109: 1694-1696. (Pubitemid 38500666)
17. Lamas GA, Lee KL, Sweeney MO, Silverman R, Leon A, Yee R, et al. Ventricular pacing or dual-chamber pacing for sinus-node dysfunction. N Engl J Med 2002; 24: 1854-1858.
18. Tse HF, Yu C, Wong KK, Tsang V, Leung YL, Ho WY, et al. Functional abnormalities in patients with permanent right ventricular pacing. J Am Coll Cardiol 2002; 40: 1451-1458.
19. Auricchio A, Stellbrink C, Block M, Sack S, Vogt J, Bakker P, et al. Effect of pacing chamber and atrioventricular delay on acute systolic function of paced patients with congestive heart failure. Circulation 1999; 99: 2993-3001. (Pubitemid 29270428)
20. Garrigue S, Bordachar P, Reuter S, Jaïs P, Kobeissi A, Gaggini G, et al. Comparison of permanent left ventricular and biventricular pacing in patients with heart failure and chronic atrial fibrillation: prospective haemodynamic study. Heart 2002; 87: 529-534.
21. Gersh BJ, Hahn CE, Prys-Roberts C. Physical criteria for measurement of left ventricular pressure and its first derivative. Cardiovasc Res 1971; 5: 32-40.
22. Rodriguez LM, Timmermans C, Nabar A, Beatty G, Wellens HJ. Variable patterns of septal activation in patients with left bundle branch block and heart failure. J Cardiovasc Electrophysiol 2003; 14: 135-141. (Pubitemid 36403545)
23. Ding LG, Hua W, Zhang S, Chu JM, Chen KP, Wang Y, et al. Decrease of plasma N-terminal pro beta-type natriuretic peptide as a predictor of clinical improvement after cardiac resynchronization therapy for heart failure. Chin Med J 2009; 122: 617-621.
24. Huang DJ. Cardiac resynchronization therapy and B-type natriuretic peptide in heart failure. Chin Med J 2009; 122: 608-609.